Details for Australian Trade Mark No. 1426217 (hide)

Owner Onyx Pharmaceuticals, Inc a corporation organized under the laws

Convention US 24 November 2010 85/185034

Service Davies Collison Cave

Various Convention priority claimed: 24 November 2010, United States of America, No. 85/185034 .* Convention priority claimed: 24 November 2010, United States of America, No. 85/185041 .

Filing Date 20 May 2011

Classes

Class 5 Pharmaceuticals

Class 42 Pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials; medical and scientific research in the fields of treatment for cancer and oncology, and in the fields of treatment of inflammation and autoimmune diseases

Event Publications

2 June 2011 Application filed

2 June 2011 Application Accepted

15 September 2011 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1426218-GOLDPINE

1426216-RELIANCE INVESTMENT MANAGEMENT